ResMed Inc.
RMD
$270.27
$2.961.11%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.35B | 1.29B | 1.28B | 1.22B | 1.22B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.35B | 1.29B | 1.28B | 1.22B | 1.22B |
| Cost of Revenue | 518.56M | 517.88M | 523.18M | 499.62M | 499.68M |
| Gross Profit | 829.44M | 773.85M | 758.91M | 724.89M | 723.51M |
| SG&A Expenses | 265.13M | 245.30M | 241.61M | 238.98M | 242.19M |
| Depreciation & Amortization | 21.30M | 18.34M | 18.68M | 19.07M | 19.25M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 891.42M | 865.47M | 864.85M | 837.20M | 841.98M |
| Operating Income | 456.57M | 426.27M | 417.24M | 387.31M | 381.22M |
| Income Before Tax | 458.05M | 417.69M | 418.32M | 383.50M | 357.73M |
| Income Tax Expenses | 78.35M | 52.65M | 73.70M | 72.14M | 65.50M |
| Earnings from Continuing Operations | 379.71M | 365.04M | 344.62M | 311.36M | 292.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 379.71M | 365.04M | 344.62M | 311.36M | 292.24M |
| EBIT | 456.57M | 426.27M | 417.24M | 387.31M | 381.22M |
| EBITDA | 513.86M | 463.68M | 457.28M | 425.58M | 418.13M |
| EPS Basic | 2.59 | 2.49 | 2.35 | 2.12 | 1.99 |
| Normalized Basic EPS | 1.97 | 1.80 | 1.79 | 1.64 | 1.59 |
| EPS Diluted | 2.58 | 2.48 | 2.34 | 2.11 | 1.98 |
| Normalized Diluted EPS | 1.97 | 1.80 | 1.78 | 1.63 | 1.58 |
| Average Basic Shares Outstanding | 146.47M | 146.72M | 146.81M | 146.86M | 146.92M |
| Average Diluted Shares Outstanding | 147.04M | 147.22M | 147.48M | 147.60M | 147.53M |
| Dividend Per Share | 0.53 | 0.53 | 0.53 | 0.53 | 0.48 |
| Payout Ratio | 20.43% | 21.29% | 22.54% | 25.02% | 24.14% |